May 1 is the day DNDN expect FDA news. My guess is that should they get approval that it may spark interest in other Therapeutic Vaccine developers e.g. PRR and VHL. Any thoughts?
ARU Arafura updates on total US$1B funding as export banks and lenders take notice; heading toward FID for Nolans
ITM iTech Minerals flags high-grade rockchip finds, boasting one sample at +18% copper. What lies underground remains to be seen
M4M Macro Metals picks up 80% in Firebird's manganese plays; mining services operations to launch if decision to mine passed